BeiGene is a startup based in China, most recent round Series-c-plus, 1 tracked investor.
Based in China, BeiGene is a startup founded in 2010. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
BeiGene is a global biotechnology company that is developing and commercializing innovative oncology medicines to improve treatment outcomes and access for patients worldwide.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.